TOP STORIES

• REGULATORY Xocova Priced at 51,851 Yen per Course with Peak Sales Put at 19.2 Billion Yen
  March 9, 2023

• REGULATORY Expert Narukawa Backs JPMA Pitch on Value-Based Pricing, but Disputes Blanket Price Maintenance for Patented Meds
  March 8, 2023

• BUSINESS Azilva, Abraxane, and More Major Meds Get Add-On PMPs under Ad-Hoc Rule in FY2023: Poll
  March 7, 2023

• BUSINESS Drug Makers Wary of Rush Demand Tied to Unprofitability Re-Pricing, Some Curb Orders
  March 7, 2023

• BUSINESS 2023 Price Cut for Top-Tier, 2nd-Tier Firms at 1-4%, Tsumura Only Original Drug Maker to See Net Rise: Jiho Poll
  March 6, 2023

• REGULATORY MHLW Unveils New List Prices for FY2023 Revision, Ad-Hoc PMP Raise for 143 Products
  March 3, 2023

• BUSINESS Nichi-Iko to Discontinue 221 Additional Products, Generic Peers Looking into Impact
  March 2, 2023

• BUSINESS Nichi-Iko Exits North American Market, Biosimilar Biz with Sagent Sell-Off
  March 1, 2023

• BUSINESS Japan Approves Pfizer’s Omicron-Tailored Vaccine for Ages 5-11
  March 1, 2023

• REGULATORY Japan Panel Backs Approval of 1st Nasal Flu Vaccine
  February 28, 2023

• REGULATORY Pfizer’s Omicron-Adapted Jab for Ages 5-11 in Line for Japan Approval
  February 28, 2023

• REGULATORY Nipro Pharma Told to Improve Biz over Violations Spanning 42 Products, Faked Records
  February 27, 2023

• REGULATORY Japan Approves Precedex for Pediatric Use, Expands Labels for Nubeqa, Rinvoq, and More
  February 27, 2023

• REGULATORY Nipro Pharma Likely to Face Business Improvement Order over Violations
  February 24, 2023

• BUSINESS Kidswell Bio Revs Up Biosimilar Push, G-Lasta, Eylea Follow-Ons in Development
  February 22, 2023

• REGULATORY Japan Eyes Two COVID Shots a Year for Elderly, High-Risk People
  February 22, 2023

• ORGANIZATION Policy Veterans’ Group Floats Proposal to Prevent Unprofitability to Stabilize Drug Supply
  February 21, 2023

• BUSINESS Shareholders OK Nichi-Iko’s Delisting, Turnaround under New Management; President to Exit March 8
  February 20, 2023

• BUSINESS ViiV Eyes More Uptake for Japan’s 1st Long-Acting HIV Med, Revs Up Development Drive
  February 17, 2023

• REGULATORY Chuikyo OKs Pricing Plan for Xocova Listing, 100 Billion Yen Threshold for Possible Re-Pricing
  February 16, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• …
• Next ›
• 最終 »